We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

AstraZeneca and Targacept Announce Results from Phase 2b Study of AZD3480 in Alzheimer’s Disease

News   Sep 16, 2008

 
AstraZeneca and Targacept Announce Results from Phase 2b Study of AZD3480 in Alzheimer’s Disease
 
 
 

RELATED ARTICLES

Statins Have Low Risk of Side Effects

News

The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients. Since statins are associated with a low risk of side effects, the benefits of taking them outweigh the risks, according to a scientific statement from the American Heart Association that reviewed multiple studies evaluating the safety and potential side effects of these drugs.

READ MORE

Multigene Test Facilitates Targeted Use of Chemotherapy for Breast Cancer

News

New results show that the multigene test used at the university hospital in Munich is indeed helpful in making more targeted use of chemotherapy treatments and thus improves prognosis of breast cancer patients.

READ MORE

Effects of Opioids on Driving Performance

News

A new study found that the influence of single analgesic doses of methadone and buprenorphine—two different opioids—on driving performance was mild and below the impairment threshold of a blood alcohol concentration of 0.5 mg ml-1.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE